MALDI-ToF Mass Spectrometry
- VeriStrat® Test
- ImmunoStrat® Protein Signatures
- Lung Cancer Risk of Recurrence Test
- Biological Pathway Protein Score
- Custom Signature Discovery
Working alongside our biopharmaceutical partners, we employ personalized and integrated approaches to uncover new solutions to diagnostic challenges with industry-leading expertise in blood-based testing.
Our diagnostic solutions leverage both genomics and proteomics to uncover comprehensive insights about the tumor biology and patient’s immune response to therapeutics in clinical development. We take a technology agnostic approach for blood-based biomarker discovery to ensure we provide the necessary solutions to fulfill your needs.
Our biomarker discovery projects include discovering novel biomarker tests with our proprietary artificial intelligence platform, developing assays for known biological targets, retrospectively gathering insights from clinical studies, and prospectively enrolling patients into clinical trials. We follow a simple biomarker evaluation process to ensure our diagnostic tests are CDx-ready.